← Eichor
Condition: Lgll Large Granular Lymphocytic Leukemia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Lgll Large Granular Lymphocytic Leukemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06530576Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia
Phase 2 · 3 location(s) · Jonathan Brammer · NCT05592015A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
Phase 1/Phase 2 · 37 location(s) · Dren Bio · NCT05475925National Longitudinal Cohort of Hematological Diseases
Phase N/A · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT04645199A Registry for People With T-cell Lymphoma
Phase N/A · 26 location(s) · Memorial Sloan Kettering Cancer Center · NCT05978141JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
Phase 2 · 2 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06716658National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia
Phase N/A · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07019766Registry of the German CLL Study Group
Phase N/A · 1 location(s) · German CLL Study Group · NCT02863692PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06530550
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.